Nuclear Medicine
DISIDA
Name:
Disida SN Radiofarma – Tc
Active Principle:
Ácido Disopropiliminodiacetico
Therapeutic Action:
It is indicated to evaluate the bile ducts by scintigraphy and quantify duodenal gastric reflux, assess the functional status of hepatic polygonal cells in case of acute or chronic cholecystitis, liver disease with or without jaundice, complete or incomplete choledochal syndromes, biliary tract atresias, fistulas bile ducts, patency control of biliodigestive anastomoses, gallbladder motor function, suspicion of hepatic hematoma or adenoma.
Nuclear Medicine
DISIDA
Name:
Disida SN Radiofarma – Tc
Active Principle:
Ácido Disopropiliminodiacetico
Therapeutic Action:
It is indicated to evaluate the bile ducts by scintigraphy and quantify duodenal gastric reflux, assess the functional status of hepatic polygonal cells in case of acute or chronic cholecystitis, liver disease with or without jaundice, complete or incomplete choledochal syndromes, biliary tract atresias, fistulas bile ducts, patency control of biliodigestive anastomoses, gallbladder motor function, suspicion of hepatic hematoma or adenoma.
RELATED PRODUCTS
-
AV45 (R+D)
AV45 (R+D)It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive... -
177Lu DOTATATE (I+D)
177Lu DOTATATE (I+D)It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut...